Popular back pain medication linked to brain health risks in some patients
The study, published online in the journal Regional Anesthesia & Pain Medicine, found that groups previously considered too young to develop the conditions faced more than twice the risk when taking gabapentin.
"Our findings indicate an association between gabapentin prescription and dementia or cognitive impairment within 10 years," the research team stated in a press release.
The drug has become increasingly popular for treating chronic pain, especially neuropathic (nerve) pain, the researchers noted in a press release.
Gabapentin — which is also used to control seizures, according to Cleveland Clinic — has relatively low addictive potential compared to traditional opioids.
Recent research has sparked new concerns over its side effects, including a possible association with neurodegeneration.
Previous findings could not confirm a specific link, especially regarding whether certain age groups are more vulnerable.
In the latest study, researchers collected data from TriNetX, a health research network containing electronic health records from 68 healthcare organizations across the U.S.
Examining anonymous records of adult patients, the team looked at groups who had been prescribed gabapentin for chronic lower back pain between 2004 and 2024 and compared them to people who hadn't received the drug. There were a total of 26,414 individuals in each group.
The researchers accounted for factors like demographics, co-existing conditions and the use of other pain-relieving drugs.
Patients who had received six or more gabapentin prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to be diagnosed with MCI within 10 years of their initial pain diagnosis, the study found.
Looking at specific age groups, people between 18 and 64 years old who received the drug were more than twice as likely to develop either condition than those who hadn't been prescribed gabapentin.
While there was no heightened risk among those aged 18 to 34 who were prescribed the drug, the risk of dementia more than doubled (and the risk of MCI more than tripled) among 35- to 49-year-olds.
Researchers observed a similar pattern among 50- to 64-year-olds.
Risks rose with prescription frequency: Patients with 12 or more prescriptions were 40% more likely to develop dementia and 65% more likely to develop MCI than those who were prescribed gabapentin between three and 11 times.
"Our findings indicate an association between gabapentin prescription and dementia or cognitive impairment within 10 years."
The study did have some limitations. As this was an observational study, no firm conclusions can be drawn about cause and effect, the researchers noted.
For more Health articles, visit www.foxnews.com/health
They also acknowledged that because the study was retrospective, they couldn't account for dose or length of gabapentin use.
The results "support the need for close monitoring of adult patients prescribed gabapentin to assess for potential cognitive decline," the researchers added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gizmodo
33 minutes ago
- Gizmodo
There's a Strange New Hole in Yellowstone National Park
Last April, geologists conducting routine maintenance at temperature logging stations in Yellowstone National Park's Norris Geyser Basin found something unexpected: a previously undocumented thermal pool of blue water. The newly identified pool, found in the Porcelain Basin subbasin, is about 13 feet (4 meters) wide, its idyllic blue water is around 109 degrees Fahrenheit (43 degrees Celsius), and the water's surface sits about one foot (30 centimeters) below the rim of the pool, according to a United States Geological Survey statement. The geologists found light-gray mud-covered rocks, including rocks up to one foot wide (30 cm), surrounding the pool. How did this feature form? According to the geologists, the clues actually paint a relatively clear picture: the pool likely resulted from a hydrothermal explosion—when liquid water turns to steam and causes underground pressure changes, creating a steam blast. Hydrothermal explosions are not uncommon at Norris Geyser Basin, which has experienced similar events before. Well-documented ones include the 1989 explosion of Porkchop Geyser. More recently, a new monitoring station installed in 2023 detected an explosion in the Porcelain Terrace area on April 15, 2024. Satellite imagery shows that the new pool did not exist before December 19, 2024. By January 6, 2025, a small cavity had begun to take shape, and on February 13, the water pool had fully formed. However, the recently installed monitoring station—which detects hydrothermal activity via infrasound (extremely low-frequency sound waves)—did not register any strong or distinct explosions during that time. It did, though, detect a number of weak acoustic signals from the direction of the pool, including on December 25, 2024, January 15, 2025, and February 11, 2025, but without an associated seismic signal that would normally accompany a strong explosion. As such, the pool likely formed after a number of smaller explosions chucked out rocks and silica mud, as opposed to a single big event. Silica-rich water then filled the resulting hole. The activity probably started on December 25, 2024, and continued in January and early February of this year. Norris Geyser Basin is the oldest and most active thermal area in Yellowstone and hosts the tallest geyser—a sporadically explosive hot water spring—on Earth. Yellowstone itself has over 10,000 thermal features, such as geysers, hot springs, steam vents, and mudpots, which attract tourists and scientists alike from all over the globe. The thermal activity is driven by an underground magma reservoir (part of the giant Yellowstone volcano complex), which heats up groundwater and triggers a series of chemical and physical reactions. Ultimately, the finding shows that even the most studied landscapes can still surprise us.
Washington Post
33 minutes ago
- Washington Post
Improve your gut health with our new Try This: Gut Check newsletter
The Washington Post's 'Try This' podcast has a new companion — the Try This: Gut Check newsletter. It's a five-part newsletter series that breaks down what science actually says about how to support gut health without stress, supplements or confusing trends. I'm Cristina Quinn, and I'll be exploring questions like: What's the deal with probiotics? Do fermented foods really help? How do you actually eat more fiber without overhauling your life? Can I throw quinoa on everything?!
Medscape
35 minutes ago
- Medscape
Bariatric Surgery: Who's Eligible Now?
This transcript has been edited for clarity. Bariatric surgery is a powerful tool for long-term weight loss, but it requires lifelong commitment to healthy eating, physical activity, supplements, and behavior change. When should you refer for bariatric surgery? The 2019 AACE/TOS/ASMBS guidelines recommend considering surgery for individuals with a BMI over 35 and at least one obesity-related condition — like type 2 diabetes, sleep apnea, or hypertension — or anyone with a BMI over also note that patients with a BMI from 30 to 34.9 and poorly controlled type 2 diabetes may be considered. The updated 2022 ASMBS guidelines recommend expanding eligibility to include a BMI over 30with weight-related conditions, especially for Asian populations who experience metabolic risk at lower most insurance plans still only cover surgery for a BMI over 35 with associated conditions or a BMI over 40. Because long-term weight loss is difficult due to biologic adaptations, I offer surgery as an option to all eligible patients so they can make an informed choice. Surgery may be especially appropriate for patients who prefer surgery over lifelong obesity medications — though they'll still need lifelong vitamin supplementation — those who have not achieved long-term success with lifestyle interventions and/or obesity medications, or those who have higher BMI, for whom obesity medications and lifestyle modifications may not be sufficient to lead to resolution of weight-related complications. Importantly, this does not have to be an either/or patients benefit from a combination of bariatric surgery and obesity medications to achieve meaningful, lasting weight loss and improvements in health. As always, shared decision making is key, including a clear discussion of risks, benefits, alternatives, and patient goals.
